Chemed - CHE Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CHE shares.
View CHE analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued twelve-month price targets for Chemed's shares. Their CHE share price forecasts range from $541.00 to $541.00. On average, they predict the company's share price to reach $541.00 in the next twelve months. This suggests a possible upside of 12.1% from the stock's current price.
View analysts price targets for CHE or view top-rated stocks among Wall Street analysts.

Chemed's stock was trading at $529.04 at the start of the year. Since then, CHE shares have decreased by 8.8% and is now trading at $482.57.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our CHE earnings forecast.

Chemed Co. (NYSE:CHE) posted its quarterly earnings results on Wednesday, July, 27th. The company reported $4.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.78 by $0.06. The firm earned $531.29 million during the quarter, compared to the consensus estimate of $538.07 million. Chemed had a net margin of 12.95% and a trailing twelve-month return on equity of 44.64%. The firm's revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.60 EPS.

Chemed declared a quarterly dividend on Friday, August 5th. Investors of record on Monday, August 15th will be given a dividend of $0.38 per share on Friday, September 2nd. This represents a $1.52 annualized dividend and a dividend yield of 0.31%. The ex-dividend date is Friday, August 12th. This is an increase from the stock's previous quarterly dividend of $0.36.
Read our dividend analysis for CHE.

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.31%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.31% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

Chemed updated its FY 2022 earnings guidance on Wednesday, August, 3rd. The company provided earnings per share (EPS) guidance of $19.30-$19.50 for the period, compared to the consensus EPS estimate of $19.47. The company issued revenue guidance of -.

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Chemed's stock is owned by many different retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (3.45%), State Street Corp (2.77%), William Blair Investment Management LLC (2.71%), JPMorgan Chase & Co. (1.92%), Victory Capital Management Inc. (1.33%) and Boston Trust Walden Corp (1.31%). Insiders that own company stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs.
View institutional ownership trends.

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CHE stock can currently be purchased for approximately $482.57.

Chemed (NYSE:CHE) has a market capitalization of $7.19 billion and generates $2.14 billion in revenue each year. The company earns $268.55 million in net income (profit) each year or $17.98 on an earnings per share basis.

The company employs 14,137 workers across the globe.

Chemed was founded in 1970.

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.